Abnormal regulation of the CDK4- and CDK6-cyclin D-INK4-retinoblastoma protein (Rb) signaling pathway is one of the most common aberrations noted in many human cancers, in particular, in GBMs, which cells show excessive CDK4/CDK6 activation [19]. This evidence concerns the gene CDK6 and cancer.